Haloperidol versus olanzapine for people with schizophrenia

To assess the clinical effects and safety of haloperidol compared to olanzapine for people with schizophrenia and schizophrenia-like illnesses.

This is a protocol.

Health topics:

Mental health > Schizophrenia & psychosis > Antipsychotic medication: atypical

Mental health > Schizophrenia & psychosis > Antipsychotic medication: other

Published:

30 October 2019

Authors:

Ibragimov K, Keane G, Carreño Glaría C, Cheng J, Llosa A

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ibragimov K, Keane G, Carreño Glaría C, Cheng J, Llosa A. Haloperidol versus olanzapine for people with schizophrenia. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD013425. DOI: 10.1002/14651858.CD013425